Search Results - "URSCHITZ, MARTINA"

Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial by Pieber, Thomas R., Arfelt, Kristine N., Cailleteau, Roman, Hart, Marlies, Kar, Soumitra, Mursic, Ines, Svehlikova, Eva, Urschitz, Martina, Haahr, Hanne

“…Aims/hypothesis This study compared the frequency of hypoglycaemia, time to hypoglycaemia and recovery from hypoglycaemia after double or triple doses of…”
Get full text

Pharmacokinetics and Pharmacodynamics of a Novel U500 Insulin Aspart Formulation: A Randomized, Double-Blind, Crossover Study in People With Type 1 Diabetes by Svehlikova, Eva, Ashcroft, Nicole L, Gatschelhofer, Christina, Gerring, David, Höller, Vera, Jezek, Jan, Lackner, Bettina, Lawrence, Fiona, Pillai, Vijay, Ratzer, Maria, Urschitz, Martina, Wolf, Michael, Pieber, Thomas R

“…To evaluate the pharmacokinetics, pharmacodynamics, and safety of a novel U500 insulin aspart formulation (AT278 U500) compared with insulin aspart (IAsp…”
Get full text

Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A Randomized, Double-Blind, Crossover Study in Men With Type 1 Diabetes by Svehlikova, Eva, Mursic, Ines, Augustin, Thomas, Magnes, Christoph, Gerring, David, Jezek, Jan, Schwarzenbacher, Daniela, Ratzer, Maria, Wolf, Michael, Howell, Sarah, Zakrzewski, Leon, Urschitz, Martina, Tschapeller, Bernd, Gatschelhofer, Christina, Feichtner, Franz, Lawrence, Fiona, Pieber, Thomas R

“…To investigate the pharmacokinetic and pharmacodynamic properties and safety of a novel formulation of insulin aspart (AT247) versus two currently marketed…”
Get full text

25-OR: Acid–Base Changes during Diabetic Ketoacidosis (DKA) in T1DM with and without SGLT2 Inhibitor (SGLT2i) by MURSIC, INES, SVEHLIKOVA, EVA, REGITTNIG, WERNER, AUGUSTIN, THOMAS, MAGNES, CHRISTOPH, EBERL, ANITA, HEISE, TIM, KLEIN, OLIVER, WOLF, MICHAEL, URSCHITZ, MARTINA, BRUNNER, MARTINA, SOURIJ, HARALD, PIEBER, THOMAS

“…Objectives: To evaluate the effect of SGLT2i on the development of DKA during insulin depletion in T1DM. Methods: Sixteen male, C-peptide negative T1DM…”
Get full text